Microangiopathic hemolytic anemia with thrombocytopenia and renal insufficiency is commonly seen in young children with:
**Question:** Microangiopathic hemolytic anemia with thrombocytopenia and renal insufficiency is commonly seen in young children with:
**Core Concept:** Microangiopathic hemolytic anemia is a condition characterized by the destruction of red blood cells in small blood vessels. Thrombocytopenia refers to a decrease in platelet count, while renal insufficiency refers to impaired kidney function. These symptoms can be associated with a specific disease or condition.
**Why the Correct Answer is Right:** The correct answer, **Option D: Hemolytic uremic syndrome (HUS)**, is a clinical entity characterized by microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency. It occurs primarily in young children and is typically preceded by gastrointestinal illness, often due to Shiga toxin-producing Escherichia coli (STEC) infections.
**Why Each Wrong Option is Incorrect:**
**Option A: Hemolytic uremic syndrome (HUS) without gastrointestinal illness:** This is incorrect because HUS is commonly preceded by gastrointestinal illness, often caused by STEC infections. If there is no gastrointestinal illness, it is likely not HUS.
**Option B: Hemolytic uremic syndrome (HUS) with only thrombocytopenia and renal insufficiency:** While HUS can present with thrombocytopenia and renal insufficiency, microangiopathic hemolytic anemia is a defining feature of HUS. If the question only asks for thrombocytopenia and renal insufficiency, the correct answer would be a different condition.
**Option C: Hemolytic uremic syndrome (HUS) without anemia:** HUS is characterized by microangiopathic hemolytic anemia, which explains the presence of anemia in the question. Without anemia, it is less likely to be HUS.
**Clinical Pearl / High-Yield Fact:** Hemolytic uremic syndrome is a serious complication of Shiga toxin-producing Escherichia coli (ETEC) infections or other causes like diarrheal diseases, malignancies, or drug reactions. Treatment options include supportive care, plasma exchange, or antibiotics, depending on the underlying cause. Early recognition and proper management are crucial to prevent complications and improve outcomes.
**Correct Answer:** Option D: Hemolytic uremic syndrome (HUS) is the correct answer because it fits the clinical presentation of microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency, and is often preceded by gastrointestinal illness due to Shiga toxin-producing Escherichia coli (ETEC) infections.